+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Insulin Pump Market Industry Trends and Global Forecasts to 2035 - Distribution by Type of Pump (Tethered Pumps and Patch Pumps), Degree of Automation, Type of Battery, Type of Diabetes Targeted, Distribution Channel and Key Geography

  • PDF Icon

    Report

  • 328 Pages
  • November 2024
  • Region: Global
  • Roots Analysis
  • ID: 6021539
Description Jump to:

The Insulin Pump Market is expected to reach USD 5.8 billion in 2024 and is anticipated to grow at a CAGR of 8% during the forecast period till 2035.

According to the World Health Organization, over 420 million people are currently suffering from diabetes worldwide. Diabetes has emerged as a leading cause of serious health issues including blindness, heart attacks, kidney failure, lower limb amputation, and strokes. The traditional treatment options for diabetes include oral medications, insulin injections and lifestyle modifications. However, conventional diabetes management techniques, characterized by multiple daily injections, are often associated with discomfort, inconvenience, and suboptimal patient outcomes. This raises several concerns related to drug delivery, including dosing inaccuracies, the risk of needlestick injuries, and variability in insulin absorption depending on the site of injection.

Given the limitations associated with diabetes drug delivery devices, insulin pumps have become a preferred option for insulin administration. These compact, lightweight devices are designed to deliver continuous or intermittent insulin infusions based on the patient's needs, offering a precise and adaptable approach to diabetes management. Notably, most insulin pumps can be worn on a belt and consist of a tube that connects the pump to an infusion set placed in the subcutaneous fatty tissue. Some insulin pumps can be worn directly on the skin as patches, allowing patients to move freely. These devices offer numerous advantages, including accurate and adjustable insulin delivery, customizable basal rates, bolus dosing during meals, enhanced comfort, and reduced risk of hypoglycemia and hyperglycemia, contributing to the enhanced quality of life. Further, insulin pumps comprise of a simple administration process that has proven to improve self-medication at-home settings, thereby reducing reliance on healthcare providers for insulin administration.

Key Market Segments

Type of Pump

  • Tethered Pumps
  • Patch Pumps

Degree of Automation

  • Manual Pumps
  • Automated / Smart Pumps

Type of Battery

  • Replaceable Batteries
  • Rechargeable Batteries

Type of Diabetes Targeted

  • Type 1 Diabetes
  • Type 2 Diabetes

Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Other Pharmacies

Key Geography

  • North America (US, Canada)
  • Europe (UK, Germany, Spain, France, Italy)
  • Asia (China, India, Japan, Pakistan)
  • Latin America (Brazil, Argentina, Mexico)
  • Middle East and North Africa (Israel, Egypt, Saudi Arabia)

 

Research Coverage:

  • An outline of the systematic research approach used for the study of insulin pump market, featuring an overview of the key assumptions, research methodologies, and quality control measures employed to ensure the accuracy and reliability of our findings.
  • An in-depth assessment of the key factors including economic, strategic, technological, and institutional drivers impacting the growth of the insulin pump industry. Further, this section highlights key factors affecting market dynamics and the strong quality control framework implemented to guarantee transparency and credibility in the insights provided to the clients.
  • An executive summary of the insights captured during our research, offering an overview of the current insulin pump market. Additionally, this section presents information on the most relevant trends, challenges and opportunities that are shaping the industry's development.
  • A brief overview of diabetes, along with information on insulin pumps and their types. The module covers the advantages and drawbacks associated with the use of insulin pumps. In addition, it discusses the anticipated future trends in this domain.
  • A detailed assessment of the current market landscape of insulin pumps, along with information on several relevant parameters, such as stage of development (under development and commercialized), launch year, type of pump (tethered pumps and patch pumps), degree of automation (manual pumps and automated / smart pumps), type of diabetes targeted (type 1 diabetes and type 2 diabetes), type of doses administered (basal and bolus), reservoir capacity and type of battery (replaceable batteries and rechargeable batteries). In addition, this section covers a detailed list of players engaged in manufacturing insulin pumps, along with analysis based on various parameters, such as year of establishment, company size (in terms of employee count), location of headquarters (North America, Europe and Asia-Pacific), type of company (public and private), and the most active players in this domain (in terms of number of insulin pumps manufactured).

  • Elaborate profiles of prominent players manufacturing insulin pumps, based across different geographies, including North America, Europe and Asia-Pacific. Each profile features a brief overview of the company (including information on its year of establishment, location of headquarters, number of employees, leadership team, business segments and contact details), financial information (if available), insulin pump portfolio, recent developments and an informed future outlook.
  • An in-depth analysis of patents that have been filed / granted in insulin pump domain, since 2021, based on several relevant parameters, such as the type of patent (granted patents, patent applications and others), patent publication year, patent application year, patent jurisdiction, Cooperative Patent Classification (CPC) symbols, type of applicant, and most active industry and non-industry players (in terms of number of patents filed / granted). In addition, it includes patent benchmarking and an insightful patent valuation analysis, highlighting the leading players (in terms of number of citations).

  • Detailed analysis of the factors that are likely to impact the growth of the insulin pump market. Further, the report also provides insights on the key drivers, potential restraints, emerging opportunities, and existing challenges in the insulin pump industry.
  • A detailed estimate of the current market size, opportunity and the future growth potential of the insulin pump industry over the next decade. Based on multiple parameters, such as likely adoption trends and through primary validations, we have provided an informed estimate on the market evolution, during the forecast period till 2035.

  • Detailed projections of the current and future opportunity within the insulin pump market based on different types of pumps, such as tethered pumps and patch pumps.
  • Detailed projections of the current and future opportunity within the insulin pump industry based on the degree of automation, such as manual pumps and automated / smart pumps.
  • Detailed projections of the current and future opportunity within the insulin pump market, based on various types of batteries, such as replaceable batteries and rechargeable batteries. 
  • Detailed projections of the current and future opportunity within the insulin pump market across different types of diabetes, such as type 1 diabetes and type 2 diabetes.
  • Detailed projections of the current and future opportunity within the insulin pump industry based on various distribution channels, such as retail pharmacies, hospital pharmacies, online pharmacies and other pharmacies.
  • Detailed predictions of the current and future opportunity within the insulin pump market across key geographical regions, such as North America, Europe, Asia, Latin America, and Middle East and North Africa.

Key Benefits of Buying this Report

  • The report offers valuable insights into revenue estimation for both the overall market and its sub-segments, in order to empower market leaders and newcomers with critical information requisite for establishing their footprint in the industry.
  • The report can be utilized by stakeholders to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a comprehensive view on the insulin pump market, covering essential information on significant market drivers, barriers, opportunities, and challenges.

Excel Data Packs (Complimentary)

  • Market Landscape
  • Patent Analysis
  • Market Size and Opportunity Analysis

Leading Market Players in the Insulin Pump Market Profiled include:

  • Beta Bionics
  • CeQur
  • EOFlow
  • Insulet Corporation 
  • LA Roche
  • MannKind
  • Medtronic
  • Medtrum Technologies
  • MicroPort

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases

3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Key Market Segmentation
3.7. Robust Quality Control
3.8. Limitations

4. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Diabetes
6.2.1. Classification of Diabetes
6.3. Insulin Pumps
6.3.1. Types of Insulin Pumps
6.3.2. Advantages of Insulin Pumps
6.3.3. Limitations of Insulin Pumps
6.4. Future Perspectives

7. INSULIN PUMPS: MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Insulin Pumps: Overall Market Landscape
7.2.1. Analysis by Stage of Development
7.2.2. Analysis by Launch Year
7.2.3. Analysis by Type of Pump
7.2.4. Analysis by Degree of Automation
7.2.5. Analysis by Type of Diabetes Targeted
7.2.6. Analysis by Type of Dose Administered
7.2.7. Analysis by Reservoir Capacity
7.2.8. Analysis by Type of Battery
7.3. Insulin Pumps: List of Manufacturer
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters
7.3.4. Analysis by Company Size and Location of Headquarters
7.3.5. Analysis by Type of Company
7.3.6. Most Active Players: Analysis by Number of Insulin Pumps Manufactured

8. COMPANY PROFILES: INSULIN PUMP MANUFACTURERS BASED IN NORTH AMERICA
8.1. Chapter Overview

8.2. Beta Bionics
8.2.1. Company Overview
8.2.2. Insulin Pumps Portfolio
8.2.3. Recent Developments and Future Outlook

8.3. Insulet
8.3.1. Company Overview
8.3.2. Insulin Pumps Portfolio
8.3.3. Recent Developments and Future Outlook

8.4. MannKind
8.4.1. Company Overview
8.4.2. Insulin Pumps Portfolio
8.4.3. Recent Developments and Future Outlook

8.5. Medtronic
8.5.1. Company Overview
8.5.2. Insulin Pumps Portfolio
8.5.3. Recent Developments and Future Outlook

8.6. Tandem Diabetes Care
8.6.1. Company Overview
8.6.2. Insulin Pumps Portfolio
8.6.3. Recent Developments and Future Outlook

9. COMPANY PROFILES: INSULIN PUMP MANUFACTURERS BASED IN EUROPE
9.1. Chapter Overview

9.2. CeQur
9.2.1. Company Overview
9.2.2. Insulin Pumps Portfolio
9.2.3. Recent Developments and Future Outlook

9.3. Roche
9.3.1. Company Overview
9.3.2. Financial Information
9.3.3. Insulin Pumps Portfolio
9.3.4. Recent Developments and Future Outlook

9.4. ViCentra
9.4.1. Company Overview
9.4.2. Insulin Pumps Portfolio
9.4.3. Recent Developments and Future Outlook

9.5. Ypsomed
9.5.1. Company Overview
9.5.2. Financial Information
9.5.3. Insulin Pumps Portfolio
9.5.4. Recent Developments and Future Outlook

10.COMPANY PROFILES: INSULIN PUMP MANUFACTURERS BASED IN ASIA-PACIFIC
10.1. Chapter Overview

10.2. EOFlow
10.2.1. Company Overview
10.2.2. Financial Information
10.2.3. Insulin Pumps Portfolio
10.2.4. Recent Developments and Future Outlook

10.3. Medtrum Technologies
10.3.1. Company Overview
10.3.2. Insulin Pumps Portfolio
10.3.3. Recent Developments and Future Outlook

10.4. MicroPort
10.4.1. Company Overview
10.4.2. Financial Information
10.4.3. Insulin Pumps Portfolio
10.4.4. Recent Developments and Future Outlook

10.5. Microtech Medical
10.5.1. Company Overview
10.5.2. Financial Information
10.5.3. Insulin Pumps Portfolio
10.5.4. Recent Developments and Future Outlook

10.6. SOOIL Development
10.6.1. Company Overview
10.6.2. Financial Information
10.6.3. Insulin Pumps Portfolio
10.6.4. Recent Developments and Future Outlook

10.7. Terumo
10.7.1. Company Overview
10.7.2. Financial Information
10.7.3. Insulin Pumps Portfolio
10.7.4. Recent Developments and Future Outlook

11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Insulin Pumps: Patent Analysis
11.3.1. Analysis by Patent Publication Year
11.3.2. Analysis by Patent Application Year
11.3.3. Analysis by Type of Patent and Publication Year
11.3.4. Analysis by Patent Jurisdiction
11.3.5. Analysis by CPC Symbols
11.3.6. Analysis by Type of Applicant
11.3.7. Leading Industry Players: Analysis by Number of Patents
11.3.8. Leading Non-industry Players: Analysis by Number of Patents
11.3.9. Leading Patent Assignees: Analysis by Number of Patents
11.4. Patent Benchmarking Analysis
11.4.1. Analysis of Patent Characteristics (CPC codes) by Leading Industry Players
11.4.2. Analysis of Leading Industry Players by Patent Characteristics (CPC codes)
11.5. Patent Valuation
11.6. Leading Patents by Number of Citations

12. MARKET IMPACT ANALYSIS
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion

13. GLOBAL INSULIN PUMPS MARKET
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Insulin Pumps Market, till 2035
13.3.1. Scenario Analysis
13.3.1.1. Conservative Scenario
13.3.1.2. Optimistic Scenario
13.4. Key Market Segmentations
13.5. Leading Industry Players

14. INSULIN PUMPS MARKET, BY TYPE OF PUMP
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Insulin Pumps Market: Distribution by Type of Pump, 2017, Current Year and 2035
14.3.1. Insulin Pumps Market for Tethered Pumps, till 2035
14.3.2. Insulin Pumps Market for Patch Pumps, till 2035
14.4. Data Triangulation and Validation

15. INSULIN PUMPS MARKET, BY DEGREE OF AUTOMATION
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Insulin Pumps Market: Distribution by Degree of Automation, 2017, Current Year and 2035
15.3.1. Insulin Pumps Market for Manual Pumps, till 2035
15.3.2. Insulin Pumps Market for Automated / Smart Pumps, till 2035
15.4. Data Triangulation and Validation

16. INSULIN PUMPS MARKET, BY TYPE OF BATTERY
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Insulin Pumps Market: Distribution by Type of Battery, 2017, Current Year and 2035
16.3.1. Insulin Pumps Market for Replaceable Batteries, till 2035
16.3.2. Insulin Pumps Market for Rechargeable Batteries, till 2035
16.4. Data Triangulation and Validation

17. INSULIN PUMPS MARKET, BY TYPE OF DIABETES TARGETED
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Insulin Pumps Market: Distribution by Type of Diabetes Targeted, 2017, Current Year and 2035
17.3.1. Insulin Pumps Market for Type 1 Diabetes, till 2035
17.3.1.1. Insulin Pumps Market for Type 1 Diabetes in North America, till 2035
17.3.1.1.1. Insulin Pumps Market for Type 1 Diabetes in the US, till 2035
17.3.1.1.2. Insulin Pumps Market for Type 1 Diabetes in Canada, till 2035
17.3.1.2. Insulin Pumps Market for Type 1 Diabetes in Europe, till 2035
17.3.1.2.1. Insulin Pumps Market for Type 1 Diabetes in the UK, till 2035
17.3.1.2.2. Insulin Pumps Market for Type 1 Diabetes in Germany, till 2035
17.3.1.2.3. Insulin Pumps Market for Type 1 Diabetes in Spain, till 2035
17.3.1.2.4. Insulin Pumps Market for Type 1 Diabetes in Italy, till 2035
17.3.1.2.5. Insulin Pumps Market for Type 1 Diabetes in France, till 2035
17.3.1.3. Insulin Pumps Market for Type 1 Diabetes in Asia, till 2035
17.3.1.3.1. Insulin Pumps Market for Type 1 Diabetes in China, till 2035
17.3.1.3.2. Insulin Pumps Market for Type 1 Diabetes in Japan, till 2035
17.3.1.3.3. Insulin Pumps Market for Type 1 Diabetes in India, till 2035
17.3.1.3.4. Insulin Pumps Market for Type 1 Diabetes in Pakistan, till 2035
17.3.1.4. Insulin Pumps Market for Type 1 Diabetes in Middle East and North Africa, till 2035
17.3.1.4.1. Insulin Pumps Market for Type 1 Diabetes in Israel, till 2035
17.3.1.4.2. Insulin Pumps Market for Type 1 Diabetes in Egypt, till 2035
17.3.1.4.3. Insulin Pumps Market for Type 1 Diabetes in Saudi Arabia, till 2035
17.3.1.5. Insulin Pumps Market for Type 1 Diabetes in Latin America, till 2035
17.3.1.5.1. Insulin Pumps Market for Type 1 Diabetes in Brazil, till 2035
17.3.1.5.2. Insulin Pumps Market for Type 1 Diabetes in Argentina, till 2035
17.3.1.5.3. Insulin Pumps Market for Type 1 Diabetes in Mexico, till 2035
17.3.2. Insulin Pumps Market for Type 2 Diabetes, till 2035
17.3.2.1. Insulin Pumps Market for Type 2 Diabetes in North America, till 2035
17.3.2.1.1. Insulin Pumps Market for Type 2 Diabetes in the US, till 2035
17.3.2.1.2. Insulin Pumps Market for Type 2 Diabetes in Canada, till 2035
17.3.2.2. Insulin Pumps Market for Type 2 Diabetes in Europe, till 2035
17.3.2.2.1. Insulin Pumps Market for Type 2 Diabetes in the UK, till 2035
17.3.2.2.2. Insulin Pumps Market for Type 2 Diabetes in Germany, till 2035
17.3.2.2.3. Insulin Pumps Market for Type 2 Diabetes in Spain, till 2035
17.3.2.2.4. Insulin Pumps Market for Type 2 Diabetes in Italy, till 2035
17.3.2.2.5. Insulin Pumps Market for Type 2 Diabetes in France, till 2035
17.3.2.3. Insulin Pumps Market for Type 2 Diabetes in Asia, till 2035
17.3.2.3.1. Insulin Pumps Market for Type 2 Diabetes in China, till 2035
17.3.2.3.2. Insulin Pumps Market for Type 2 Diabetes in Japan, till 2035
17.3.2.3.3. Insulin Pumps Market for Type 2 Diabetes in India, till 2035
17.3.2.3.4. Insulin Pumps Market for Type 2 Diabetes in Pakistan, till 2035
17.3.2.4. Insulin Pumps Market for Type 2 Diabetes in Middle East and North Africa, till 2035
17.3.2.4.1. Insulin Pumps Market for Type 2 Diabetes in Israel, till 2035
17.3.2.4.2. Insulin Pumps Market for Type 2 Diabetes in Egypt, till 2035
17.3.2.4.3. Insulin Pumps Market for Type 2 Diabetes in Saudi Arabia, till 2035
17.3.2.5. Insulin Pumps Market for Type 2 Diabetes in Latin America, till 2035
17.3.2.5.1. Insulin Pumps Market for Type 2 Diabetes in Brazil, till 2035
17.3.2.5.2. Insulin Pumps Market for Type 2 Diabetes in Argentina, till
17.3.2.5.3. Insulin Pumps Market for Type 2 Diabetes in Mexico, till 2035
17.4. Data Triangulation and Validation

18. INSULIN PUMPS MARKET, BY DISTRIBUTION CHANNEL
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Insulin Pumps Market: Distribution by Distribution Channel, 2017, Current Year and 2035
18.3.1. Insulin Pumps Market for Retail Pharmacies, till 2035
18.3.2. Insulin Pumps Market for Hospital Pharmacies, till 2035
18.3.3. Insulin Pumps Market for Online Pharmacies, till 2035
18.3.4. Insulin Pumps Market for Other Pharmacies, till 2035
18.4. Data Triangulation and Validation

19. INSULIN PUMPS MARKET, BY GEOGRAPHY
19.1. Chapter Overview
19.2. Assumptions and Methodology
19.3. Insulin Pumps Market: Distribution by Geography, 2017, Current Year and 2035
19.3.1. Insulin Pumps Market in North America, till 2035
19.3.1.1. Insulin Pumps Market in the US, till 2035
19.3.1.2. Insulin Pumps Market in Canada, till 2035
19.3.2. Insulin Pumps Market in Europe, till 2035
19.3.2.1. Insulin Pumps Market in the UK, till 2035
19.3.2.2. Insulin Pumps Market in Germany, till 2035
19.3.2.3. Insulin Pumps Market in Spain, till 2035
19.3.2.4. Insulin Pumps Market in Italy, till 2035
19.3.2.5. Insulin Pumps Market in France, till 2035
19.3.3. Insulin Pumps Market in Asia, till 2035
19.3.3.1. Insulin Pumps Market in China, till 2035
19.3.3.2. Insulin Pumps Market in Japan, till 2035
19.3.3.3. Insulin Pumps Market in India, till 2035
19.3.3.4. Insulin Pumps Market in Pakistan, till 2035
19.3.4. Insulin Pumps Market in Middle East and North Africa, till 2035
19.3.4.1. Insulin Pumps Market in Israel, till 2035
19.3.4.2. Insulin Pumps Market in Egypt, till 2035
19.3.4.3. Insulin Pumps Market in Saudi Arabia, till 2035
19.3.5. Insulin Pumps Market in Latin America, till 2035
19.3.5.1. Insulin Pumps Market in Brazil, till 2035
19.3.5.2. Insulin Pumps Market in Argentina, till 2035
19.3.5.3. Insulin Pumps Market in Mexico, till 2035
19.4. Insulin Pumps Market, By Geography: Market Dynamics Assessment
19.4.1. Penetration Growth (P-G) Matrix
19.4.2. Market Movement Analysis
19.5. Data Triangulation and Validation

20. CONCLUDING REMARKS21. EXECUTIVE INSIGHTSAPPENDIX I: TABULATED DATAAPPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Key Market Segmentation
Figure 3.3 Market Dynamics: Robust Quality Control
Figure 4.1 Lessons Learnt from Past Recessions
Figure 5.1 Executive Summary: Insulin Pumps Market Landscape
Figure 5.2 Executive Summary: Patent Analysis
Figure 5.3 Executive Summary: Market Forecast and Opportunity Analysis
Figure 6.1 Classification of Diabetes
Figure 7.1 Insulin Pumps: Distribution by Stage of Development
Figure 7.2 Insulin Pumps: Distribution by Launch Year
Figure 7.3 Insulin Pumps: Distribution by Type of Pump
Figure 7.4 Insulin Pumps: Distribution by Degree of Automation
Figure 7.5 Insulin Pumps: Distribution by Type of Diabetes Targeted
Figure 7.6 Insulin Pumps: Distribution by Type of Dose Administered
Figure 7.7 Insulin Pumps: Distribution by Reservoir Capacity
Figure 7.8 Insulin Pumps: Distribution by Type of Battery
Figure 7.9 Insulin Pump Manufacturers: Distribution by Year of Establishment
Figure 7.10 Insulin Pump Manufacturers: Distribution by Company Size
Figure 7.11 Insulin Pump Manufacturers: Distribution by Location of Headquarters (Region)
Figure 7.12 Insulin Pump Manufacturers: Distribution by Location of Headquarters (Country)
Figure 7.13 Insulin Pump Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 7.14 Insulin Pump Manufacturers: Distribution by Type of Company
Figure 7.15 Most Active Players: Distribution by Number of Insulin Pumps Manufactured
Figure 8.1 Insulet: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Figure 8.2 MannKind: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Figure 8.3 Medtronic: Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
Figure 8.4 Tandem Diabetes Care: Consolidated Financial Details (USD Million)
Figure 9.1 Roche: Business Segment-wise Revenues and Consolidated Financial Details (CHF Billion)
Figure 9.2 Ypsomed: Business Segment-wise Revenues and Consolidated Financial Details (CHF Million)
Figure 10.1 MicroPort: Consolidated Financial Details (USD Million)
Figure 10.2 MicroTech Medical: Business Segment-wise Revenues and Consolidated Financial Details (RMB Million)
Figure 10.3 Terumo: Consolidated Financial Details (Yen Billion)
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, Since-2021
Figure 11.3 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Since-2005
Figure 11.4 Patent Analysis: Year-wise Distribution of Granted Patents, Patent Applications and Other Patents, Since-2021
Figure 11.5 Patent Analysis: Distribution by Patent Jurisdiction
Figure 11.6 Patent Analysis: Distribution by CPC Symbols
Figure 11.7 Patent Analysis: Cumulative Year-wise Trend by Type of Applicant
Figure 11.8 Leading Industry Players: Distribution by Number of Patents
Figure 11.9 Leading Non-industry Players: Distribution by Number of Patents
Figure 11.10 Leading Patent Assignees: Distribution by Number of Patents
Figure 11.11 Patent Benchmarking Analysis: Distribution of Patent Characteristics (CPC Codes) by Leading Industry Players
Figure 11.12 Patent Benchmarking Analysis: Distribution of Leading Industry Players by Patent Characteristics (CPC Codes)
Figure 11.13 Patent Analysis: Distribution by Patent Age
Figure 11.14 Insulin Pump: Patent Valuation
Figure 13.1 Global Insulin Pumps Market, till 2035 (Million Units Sold, USD Billion)
Figure 13.2 Global Insulin Pumps Market, till 2035: Conservative Scenario (Million Units Sold, USD Billion)
Figure 13.3 Global Insulin Pumps Market, till 2035: Optimistic Scenario (Million Units Sold, USD Billion)
Figure 14.1 Insulin Pumps Market: Distribution by Type of Pump, 2017, Current Year and 2035 (USD Billion)
Figure 14.2 Insulin Pumps Market for Tethered Pumps, till 2035 (Million Units Sold, USD Billion)
Figure 14.3 Insulin Pumps Market for Patch Pumps, till 2035 (Million Units Sold, USD Billion)
Figure 15.1 Insulin Pumps Market: Distribution by Degree of Automation, 2017, Current Year and 2035 (USD Billion)
Figure 15.2 Insulin Pumps Market for Manual Pumps, till 2035 (Million Units Sold, USD Billion)
Figure 15.3 Insulin Pumps Market for Smart / Automated Pumps, till 2035 (Million Units Sold, USD Billion)
Figure 16.1 Insulin Pumps Market: Distribution by Type of Battery, 2017, Current Year and 2035 (USD Billion)
Figure 16.2 Insulin Pumps Market for Replaceable Batteries, till 2035 (Million Units Sold, USD Billion)
Figure 16.3 Insulin Pumps Market for Rechargeable Batteries, till 2035 (Million Units Sold, USD Billion)
Figure 17.1 Insulin Pumps Market: Distribution by Type of Diabetes Targeted, 2017, Current Year and 2035 (USD Billion)
Figure 17.2 Insulin Pumps Market for Type 1 Diabetes, till 2035 (Million Units Sold, USD Billion)
Figure 17.3 Insulin Pumps Market for Type 1 Diabetes in North America, till 2035 (Million Units Sold, USD Billion)
Figure 17.4 Insulin Pumps Market for Type 1 Diabetes in the US, till 2035 (Million Units Sold, USD Billion)
Figure 17.5 Insulin Pumps Market for Type 1 Diabetes in Canada, till 2035 (Million Units Sold, USD Billion)
Figure 17.6 Insulin Pumps Market for Type 1 Diabetes in Europe, till 2035 (Million Units Sold, USD Billion)
Figure 17.7 Insulin Pumps Market for Type 1 Diabetes in the UK, till 2035 (Million Units Sold, USD Billion)
Figure 17.8 Insulin Pumps Market for Type 1 Diabetes in Germany, till 2035 (Million Units Sold, USD Billion)
Figure 17.9 Insulin Pumps Market for Type 1 Diabetes in Spain, till 2035 (Million Units Sold, USD Billion)
Figure 17.10 Insulin Pumps Market for Type 1 Diabetes in Italy, till 2035 (Million Units Sold, USD Billion)
Figure 17.11 Insulin Pumps Market for Type 1 Diabetes in France, till 2035 (Million Units Sold, USD Billion)
Figure 17.12 Insulin Pumps Market for Type 1 Diabetes in Asia, till 2035 (Million Units Sold, USD Billion)
Figure 17.13 Insulin Pumps Market for Type 1 Diabetes in China, till 2035 (Million Units Sold, USD Billion)
Figure 17.14 Insulin Pumps Market for Type 1 Diabetes in Japan, till 2035 (Million Units Sold, USD Billion)
Figure 17.15 Insulin Pumps Market for Type 1 Diabetes in India, till 2035 (Million Units Sold, USD Billion)
Figure 17.16 Insulin Pumps Market for Type 1 Diabetes in Pakistan, till 2035 (Million Units Sold, USD Billion)
Figure 17.17 Insulin Pumps Market for Type 1 Diabetes in Middle East and North Africa, till 2035 (Million Units Sold, USD Billion)
Figure 17.18 Insulin Pumps Market for Type 1 Diabetes in Israel, till 2035 (Million Units Sold, USD Billion)
Figure 17.19 Insulin Pumps Market for Type 1 Diabetes in Egypt, till 2035 (Million Units Sold, USD Billion)
Figure 17.20 Insulin Pumps Market for Type 1 Diabetes in Saudi Arabia, till 2035 (Million Units Sold, USD Billion)
Figure 17.21 Insulin Pumps Market for Type 1 Diabetes in Latin America, till 2035 (Million Units Sold, USD Billion)
Figure 17.22 Insulin Pumps Market for Type 1 Diabetes in Brazil, till 2035 (Million Units Sold, USD Billion)
Figure 17.23 Insulin Pumps Market for Type 1 Diabetes in Argentina, till 2035 (Million Units Sold, USD Billion)
Figure 17.24 Insulin Pumps Market for Type 1 Diabetes in Mexico, till 2035 (Million Units Sold, USD Billion)
Figure 17.25 Insulin Pumps Market for Type 2 Diabetes, till 2035 (Million Units Sold, USD Billion)
Figure 17.26 Insulin Pumps Market for Type 2 Diabetes in North America, till 2035 (Million Units Sold, USD Billion)
Figure 17.27 Insulin Pumps Market for Type 2 Diabetes in the US, till 2035 (Million Units Sold, USD Billion)
Figure 17.28 Insulin Pumps Market for Type 2 Diabetes in Canada, till 2035 (Million Units Sold, USD Billion)
Figure 17.29 Insulin Pumps Market for Type 2 Diabetes in Europe, till 2035 (Million Units Sold, USD Billion)
Figure 17.30 Insulin Pumps Market for Type 2 Diabetes in the UK, till 2035 (Million Units Sold, USD Billion)
Figure 17.31 Insulin Pumps Market for Type 2 Diabetes in Germany, till 2035 (Million Units Sold, USD Billion)
Figure 17.32 Insulin Pumps Market for Type 1 Diabetes in Spain, till 2035 (Million Units Sold, USD Billion)
Figure 17.33 Insulin Pumps Market for Type 2 Diabetes in Italy, till 2035 (Million Units Sold, USD Billion)
Figure 17.34 Insulin Pumps Market for Type 2 Diabetes in France, till 2035 (Million Units Sold, USD Billion)
Figure 17.35 Insulin Pumps Market for Type 2 Diabetes in Asia, till 2035 (Million Units Sold, USD Billion)
Figure 17.36 Insulin Pumps Market for Type 2 Diabetes in China, till 2035 (Million Units Sold, USD Billion)
Figure 17.37 Insulin Pumps Market for Type 2 Diabetes in Japan, till 2035 (Million Units Sold, USD Billion)
Figure 17.38 Insulin Pumps Market for Type 2 Diabetes in India, till 2035 (Million Units Sold, USD Billion)
Figure 17.39 Insulin Pumps Market for Type 2 Diabetes in Pakistan, till 2035 (Million Units Sold, USD Billion)
Figure 17.40 Insulin Pumps Market for Type 2 Diabetes in Middle East and North Africa, till 2035 (Million Units Sold, USD Billion)
Figure 17.41 Insulin Pumps Market for Type 2 Diabetes in Israel, till 2035 (Million Units Sold, USD Billion)
Figure 17.42 Insulin Pumps Market for Type 2 Diabetes in Egypt, till 2035 (Million Units Sold, USD Billion)
Figure 17.43 Insulin Pumps Market for Type 2 Diabetes in Saudi Arabia, till 2035 (Million Units Sold, USD Billion)
Figure 17.44 Insulin Pumps Market for Type 2 Diabetes in Latin America, till 2035 (Million Units Sold, USD Billion)
Figure 17.45 Insulin Pumps Market for Type 2 Diabetes in Brazil, till 2035 (Million Units Sold, USD Billion)
Figure 17.46 Insulin Pumps Market for Type 2 Diabetes in Argentina, till 2035 (Million Units Sold, USD Billion)
Figure 17.47 Insulin Pumps Market for Type 2 Diabetes in Mexico, till 2035 (Million Units Sold, USD Billion)
Figure 18.1 Insulin Pumps Market: Distribution by Distribution Channel, 2017, Current Year and 2035 (USD Billion)
Figure 18.2 Insulin Pumps Market for Retail Pharmacies, till 2035 (Million Units Sold, USD Billion)
Figure 18.3 Insulin Pumps Market for Online Pharmacies, till 2035 (Million Units Sold, USD Billion)
Figure 18.4 Insulin Pumps Market for Hospital Pharmacies, till 2035 (Million Units Sold, USD Billion)
Figure 18.5 Insulin Pumps Market for Other Pharmacies, till 2035 (Million Units Sold, USD Billion)
Figure 19.1 Insulin Pumps Market: Distribution by Geography, 2017, Current Year and 2035 (USD Billion)
Figure 19.2 Insulin Pumps Market in North America, till 2035 (Million Units Sold, USD Billion)
Figure 19.3 Insulin Pumps Market in the US, till 2035 (Million Units Sold, USD Billion)
Figure 19.4 Insulin Pumps Market in Canada, till 2035 (Million Units Sold, USD Billion)
Figure 19.5 Insulin Pumps Market in Europe, till 2035 (Million Units Sold, USD Billion)
Figure 19.6 Insulin Pumps Market in the UK, till 2035 (Million Units Sold, USD Billion)
Figure 19.7 Insulin Pumps Market in Germany, till 2035 (Million Units Sold, USD Billion)
Figure 19.8 Insulin Pumps Market in Spain, till 2035 (Million Units Sold, USD Billion)
Figure 19.9 Insulin Pumps Market in Italy, till 2035 (Million Units Sold, USD Billion)
Figure 19.10 Insulin Pumps Market in France, till 2035 (Million Units Sold, USD Billion)
Figure 19.11 Insulin Pumps Market in Asia, till 2035 (Million Units Sold, USD Billion)
Figure 19.12 Insulin Pumps Market in China, till 2035 (Million Units Sold, USD Billion)
Figure 19.13 Insulin Pumps Market in Japan, till 2035 (Million Units Sold, USD Billion)
Figure 19.14 Insulin Pumps Market in India, till 2035 (Million Units Sold, USD Billion)
Figure 19.15 Insulin Pumps Market in Pakistan, till 2035 (Million Units Sold, USD Billion)
Figure 19.16 Insulin Pumps Market in Middle East and North Africa, till 2035 (Million Units Sold, USD Billion)
Figure 19.17 Insulin Pumps Market in Israel, till 2035 (Million Units Sold, USD Billion)
Figure 19.18 Insulin Pumps Market in Egypt, till 2035 (Million Units Sold, USD Billion)
Figure 19.19 Insulin Pumps Market in Saudi Arabia, till 2035 (Million Units Sold, USD Billion)
Figure 19.20 Insulin Pumps Market in Latin America, till 2035 (Million Units Sold, USD Billion)
Figure 19.21 Insulin Pumps Market in Brazil, till 2035 (Million Units Sold, USD Billion)
Figure 19.22 Insulin Pumps Market in Argentina, till 2035 (Million Units Sold, USD Billion)
Figure 19.23 Insulin Pumps Market in Mexico, till 2035 (Million Units Sold, USD Billion)
Figure 19.24 Penetration Growth (P-G) Matrix: Geography
Figure 19.25 Market Movement Analysis: Geography
Figure 20.1 Concluding Remarks: Insulin Pumps Market Landscape
Figure 20.2 Concluding Remarks: Patent Analysis
Figure 20.3 Concluding Remarks: Market Sizing and Opportunity Analysis

LIST OF TABLES
Table 6.1 Blood Sugar Levels
Table 7.1 Insulin Pumps: Information on Stage of Development, Launch Year and Type of Pump
Table 7.2 Insulin Pumps: Information on Degree of Automation, Type of Diabetes Targeted and Type of Dose Administered
Table 7.3 Insulin Pumps: Information on Reservoir Capacity and Type of Battery
Table 7.4 Insulin Pumps: Information on Insulin Name, Target Patient Population, Availability of Software / Mobile App, Regulatory Approval Compliance and Price of Pump
Table 8.1 Insulin Pump Manufacturers in North America: List of Companies Profiled
Table 8.2 Beta Bionics: Company Overview
Table 8.3 Beta Bionics: Insulin Pumps Portfolio
Table 8.4 Beta Bionics: Recent Developments and Future Outlook
Table 8.5 Insulet: Company Overview
Table 8.6 Insulet: Insulin Pumps Portfolio
Table 8.7 Insulet: Recent Developments and Future Outlook
Table 8.8 MannKind: Company Overview
Table 8.9 MannKind: Insulin Pumps Portfolio
Table 8.10 MannKind: Recent Developments and Future Outlook
Table 8.11 Medtronic: Company Overview
Table 8.12 Medtronic: Insulin Pumps Portfolio
Table 8.13 Medtronic: Recent Developments and Future Outlook
Table 8.14 Tandem Diabetes Care: Company Overview
Table 8.15 Tandem Diabetes Care: Insulin Pumps Portfolio
Table 8.16 Tandem Diabetes Care: Recent Developments and Future Outlook
Table 9.1 Insulin Pump Manufacturers in Europe: List of Companies Profiled
Table 9.2 CeQur: Company Overview
Table 9.3 CeQur: Insulin Pumps Portfolio
Table 9.4 CeQur: Recent Developments and Future Outlook
Table 9.5 Roche: Company Overview
Table 9.6 Roche: Insulin Pumps Portfolio
Table 9.7 Roche: Recent Developments and Future Outlook
Table 9.8 ViCentra: Company Overview
Table 9.9 ViCentra: Insulin Pumps Portfolio
Table 9.10 Terumo: Company Overview
Table 9.11 Terumo: Insulin Pumps Portfolio
Table 9.12 Terumo: Recent Developments and Future Outlook
Table 9.13 Ypsomed: Company Overview
Table 9.14 Ypsomed Medical: Insulin Pumps Portfolio
Table 9.15 Ypsomed: Recent Developments and Future Outlook
Table 10.1 Insulin Pump Manufacturers in Asia Pacific: List of Companies Profiled
Table 10.2 EOFlow: Company Overview
Table 10.3 EOFlow: Insulin Pumps Portfolio
Table 10.4 EOFlow: Recent Developments and Future Outlook
Table 10.5 Medtrum Technologies: Company Overview
Table 10.6 Medtrum Technologies: Insulin Pumps Portfolio
Table 10.7 MicroPort: Company Overview
Table 10.8 MicroPort: Insulin Pumps Portfolio
Table 10.9 MicroPort: Recent Developments and Future Outlook
Table 10.10 MicroTech Medical: Company Overview
Table 10.11 MicroTech Medical: Insulin Pumps Portfolio
Table 10.12 SOOIL Development: Company Overview
Table 10.13 SOOIL Development: Insulin Pumps Portfolio
Table 10.14 SOOIL Development: Recent Developments and Future Outlook
Table 11.1 Patent Analysis: Top CPC Sections
Table 11.2 Patent Analysis: Top CPC Symbols
Table 11.3 Patent Analysis: Top CPC Codes
Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 11.7 Patent Portfolio: List of Leading Patents (By Number of Citations)
Table 21.1 Company Snapshot: Mid-sized Company
Table 22.1 Insulin Pumps: Distribution by Stage of Development
Table 22.2 Insulin Pumps: Distribution by Launch Year
Table 22.3 Insulin Pumps: Distribution by Type of Pump
Table 22.4 Insulin Pumps: Distribution by Degree of Automation
Table 22.5 Insulin Pumps: Distribution by Type of Diabetes Targeted
Table 22.6 Insulin Pumps: Distribution by Type of Dose Administered
Table 22.7 Insulin Pumps: Distribution by Insulin Storage Capacity
Table 22.8 Insulin Pumps: Distribution by Type of Battery
Table 22.9 Insulin Pump Manufacturers: Distribution Year of Establishment
Table 22.10 Insulin Pump Manufacturers: Distribution by Company Size
Table 22.11 Insulin Pump Manufacturers: Distribution by Location of Headquarters (Region)
Table 22.12 Insulin Pump Manufacturers: Distribution by Location of Headquarters (Country)
Table 22.13 Insulin Pump Manufacturers: Distribution by Company Size and Location of Headquarters
Table 22.14 Insulin Pump Manufacturers: Distribution by Type of Company
Table 22.15 Most Active Players: Distribution by Number of Devices Manufactured
Table 22.16 Insulet: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Table 22.17 MannKind: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Table 22.18 Medtronic: Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
Table 22.19 Tandem Diabetes Care: Consolidated Financial Details (USD Million)
Table 22.20 Roche: Business Segment-wise Revenues and Consolidated Financial Details (CHF Billion)
Table 22.21 Terumo: Consolidated Financial Details (Yen Billion)
Table 22.22 Ypsomed: Business Segment-wise Revenues and Consolidated Financial Details (CHF Million)
Table 22.23 MicroPort: Consolidated Financial Details (USD Million)
Table 22.24 MicroTech Medical: Business Segment-wise Revenues and Consolidated Financial Details (RMB Million)
Table 22.25 Patent Analysis: Distribution by Type of Patent
Table 22.26 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, Since 2021
Table 22.27 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Since 2005
Table 22.28 Patent Analysis: Year-wise Distribution of Granted Patents and Patent Applications, Since 2005
Table 22.29 Patent Analysis: Distribution by Patent Jurisdiction
Table 22.30 Patent Analysis: Cumulative Year-wise Trend by Type of Applicant
Table 22.31 Leading Industry Players: Distribution by Number of Patents
Table 22.32 Leading Non-Industry Players: Distribution by Number of Patents
Table 22.33 Leading Patent Assignees: Distribution by Number of Patents
Table 22.34 Patent Analysis: Distribution by Patent Age
Table 22.35 Insulin Pumps: Patent Valuation
Table 22.36 Global Insulin Pumps Market, Historical Trends, till-2035 (Million Units Sold, USD Billion)
Table 22.37 Global Insulin Pumps Market, till 2035: Conservative Scenario (Million Units Sold, USD Billion)
Table 22.38 Global Insulin Pumps Market, till 2035: Optimistic Scenario (Million Units Sold, USD Billion)
Table 22.39 Insulin Pumps Market: Distribution by Type of Pump, 2017, Current Year and 2035 (USD Billion)
Table 22.40 Insulin Pumps Market for Tethered Pumps, till 2035 (Million Units Sold, USD Billion)
Table 22.41 Insulin Pumps Market for Patch Pumps, till 2035 (Million Units Sold, USD Billion)
Table 22.42 Insulin Pumps Market: Distribution by Degree of Automation, 2017, Current Year and 2035 (USD Billion)
Table 22.43 Insulin Pumps Market for Manual Pumps, till 2035 (Million Units Sold, USD Billion)
Table 22.44 Insulin Pumps Market for Automated / Smart Pumps, till 2035 (Million Units Sold, USD Billion)
Table 22.45 Insulin Pumps Market: Distribution by Type of Battery, 2017, Current Year and 2035 (USD Billion)
Table 22.46 Insulin Pumps Market for Replaceable Batteries, till 2035 (Million Units Sold, USD Billion)
Table 22.47 Insulin Pumps Market for Rechargeable Batteries, till 2035 (Million Units Sold, USD Billion)
Table 22.48 Insulin Pumps Market: Distribution by Type of Diabetes Targeted, 2017, Current Year and 2035 (USD Billion)
Table 22.49 Insulin Pumps Market for Type 1 Diabetes, till 2035 (Million Units Sold, USD Billion)
Table 22.50 Insulin Pumps Market for Type 1 Diabetes in North America, till 2035 (Million Units Sold, USD Billion)
Table 22.51 Insulin Pumps Market for Type 1 Diabetes in US, till 2035 (Million Units Sold, USD Billion)
Table 22.52 Insulin Pumps Market for Type 1 Diabetes in Canada, till 2035 (Million Units Sold, USD Billion)
Table 22.53 Insulin Pumps Market for Type 1 Diabetes in Europe, till 2035 (Million Units Sold, USD Billion)
Table 22.54 Insulin Pumps Market for Type 1 Diabetes in UK, till 2035 (Million Units Sold, USD Billion)
Table 22.55 Insulin Pumps Market for Type 1 Diabetes in Germany, till 2035 (Million Units Sold, USD Billion)
Table 22.56 Insulin Pumps Market for Type 1 Diabetes in Spain, till 2035 (Million Units Sold, USD Billion)
Table 22.57 Insulin Pumps Market for Type 1 Diabetes in Italy, till 2035 (Million Units Sold, USD Billion)
Table 22.58 Insulin Pumps Market for Type 1 Diabetes in France, till 2035 (Million Units Sold, USD Billion)
Table 22.59 Insulin Pumps Market for Type 1 Diabetes in Asia, till 2035 (Million Units Sold, USD Billion)
Table 22.60 Insulin Pumps Market for Type 1 Diabetes in China, till 2035 (Million Units Sold, USD Billion)
Table 22.61 Insulin Pumps Market for Type 1 Diabetes in Japan, till 2035 (Million Units Sold, USD Billion)
Table 22.62 Insulin Pumps Market for Type 1 Diabetes in India, till 2035 (Million Units Sold, USD Billion)
Table 22.63 Insulin Pumps Market for Type 1 Diabetes in Pakistan, till 2035 (Million Units Sold, USD Billion)
Table 22.64 Insulin Pumps Market for Type 1 Diabetes in Middle East and North Africa, till 2035 (Million Units Sold, USD Billion)
Table 22.65 Insulin Pumps Market for Type 1 Diabetes in Israel, till 2035 (Million Units Sold, USD Billion)
Table 22.66 Insulin Pumps Market for Type 1 Diabetes in Egypt, till 2035 (Million Units Sold, USD Billion)
Table 22.67 Insulin Pumps Market for Type 1 Diabetes in Saudi Arabia, till 2035 (Million Units Sold, USD Billion)
Table 22.68 Insulin Pumps Market for Type 1 Diabetes in Latin America, till 2035 (Million Units Sold, USD Billion)
Table 22.69 Insulin Pumps Market for Type 1 Diabetes in Brazil, till 2035 (Million Units Sold, USD Billion)
Table 22.70 Insulin Pumps Market for Type 1 Diabetes in Argentina, till 2035 (Million Units Sold, USD Billion)
Table 22.71 Insulin Pumps Market for Type 1 Diabetes in Mexico, till 2035 (Million Units Sold, USD Billion)
Table 22.72 Insulin Pumps Market for Type 2 Diabetes, till 2035 (Million Units Sold, USD Billion)
Table 22.73 Insulin Pumps Market for Type 2 Diabetes in North America, till 2035 (Million Units Sold, USD Billion)
Table 22.74 Insulin Pumps Market for Type 2 Diabetes in US, till 2035 (Million Units Sold, USD Billion)
Table 22.75 Insulin Pumps Market for Type 2 Diabetes in Canada, till 2035 (Million Units Sold, USD Billion)
Table 22.76 Insulin Pumps Market for Type 2 Diabetes in Europe, till 2035 (Million Units Sold, USD Billion)
Table 22.77 Insulin Pumps Market for Type 2 Diabetes in UK, till 2035 (Million Units Sold, USD Billion)
Table 22.78 Insulin Pumps Market for Type 2 Diabetes in Germany, till 2035 (Million Units Sold, USD Billion)
Table 22.79 Insulin Pumps Market for Type 2 Diabetes in Spain, till 2035 (Million Units Sold, USD Billion)
Table 22.80 Insulin Pumps Market for Type 2 Diabetes in Italy, till 2035 (Million Units Sold, USD Billion)
Table 22.81 Insulin Pumps Market for Type 2 Diabetes in France, till 2035 (Million Units Sold, USD Billion)
Table 22.82 Insulin Pumps Market for Type 2 Diabetes in Asia, till 2035 (Million Units Sold, USD Billion)
Table 22.83 Insulin Pumps Market for Type 2 Diabetes in China, till 2035 (Million Units Sold, USD Billion)
Table 22.84 Insulin Pumps Market for Type 2 Diabetes in Japan, till 2035 (Million Units Sold, USD Billion)
Table 22.85 Insulin Pumps Market for Type 2 Diabetes in India, till 2035 (Million Units Sold, USD Billion)
Table 22.86 Insulin Pumps Market for Type 2 Diabetes in Pakistan, till 2035 (Million Units Sold, USD Billion)
Table 22.87 Insulin Pumps Market for Type 2 Diabetes in Middle East and North Africa, till 2035 (Million Units Sold, USD Billion)
Table 22.88 Insulin Pumps Market for Type 2 Diabetes in Israel, till 2035 (Million Units Sold, USD Billion)
Table 22.89 Insulin Pumps Market for Type 2 Diabetes in Egypt, till 2035 (Million Units Sold, USD Billion)
Table 22.90 Insulin Pumps Market for Type 2 Diabetes in Saudi Arabia, till 2035 (Million Units Sold, USD Billion)
Table 22.91 Insulin Pumps Market for Type 2 Diabetes in Latin America, till 2035 (Million Units Sold, USD Billion)
Table 22.92 Insulin Pumps Market for Type 2 Diabetes in Brazil, till 2035 (Million Units Sold, USD Billion)
Table 22.93 Insulin Pumps Market for Type 2 Diabetes in Argentina, till 2035 (Million Units Sold, USD Billion)
Table 22.94 Insulin Pumps Market for Type 2 Diabetes in Mexico, till 2035 (Million Units Sold, USD Billion)
Table 22.95 Insulin Pumps Market: Distribution by Distribution Channel, 2017, Current Year and 2035 (USD Billion)
Table 22.96 Insulin Pumps Market for Retail Pharmacies, till 2035 (Million Units Sold, USD Billion)
Table 22.97 Insulin Pumps Market for Online Pharmacies, till 2035 (Million Units Sold, USD Billion)
Table 22.98 Insulin Pumps Market for Hospital Pharmacies, till 2035 (Million Units Sold, USD Billion)
Table 22.99 Insulin Pumps Market for Other Pharmacies, till 2035 (Million Units Sold, USD Billion)
Table 22.100 Insulin Pumps Market: Distribution by Geography, 2017, Current Year and 2035 (USD Billion)
Table 22.101 Insulin Pumps Market in North America, till 2035 (Million Units Sold, USD Billion)
Table 22.102 Insulin Pumps Market in US, till 2035 (Million Units Sold, USD Billion)
Table 22.103 Insulin Pumps Market in Canada, till 2035 (Million Units Sold, USD Billion)
Table 22.104 Insulin Pumps Market in Europe, till 2035 (Million Units Sold, USD Billion)
Table 22.105 Insulin Pumps Market in UK, till 2035 (Million Units Sold, USD Billion)
Table 22.106 Insulin Pumps Market in Germany, till 2035 (Million Units Sold, USD Billion)
Table 22.107 Insulin Pumps Market in Spain, till 2035 (Million Units Sold, USD Billion)
Table 22.108 Insulin Pumps Market in Italy, till 2035 (Million Units Sold, USD Billion)
Table 22.109 Insulin Pumps Market in France, till 2035 (Million Units Sold, USD Billion)
Table 22.110 Insulin Pumps Market in Asia, till 2035 (Million Units Sold, USD Billion)
Table 22.111 Insulin Pumps Market in China, till 2035 (Million Units Sold, USD Billion)
Table 22.112 Insulin Pumps Market in Japan, till 2035 (Million Units Sold, USD Billion)
Table 22.113 Insulin Pumps Market in India, till 2035 (Million Units Sold, USD Billion)
Table 22.114 Insulin Pumps Market in Pakistan, till 2035 (Million Units Sold, USD Billion)
Table 22.115 Insulin Pumps Market in Middle East and North Africa, till 2035 (Million Units Sold, USD Billion)
Table 22.116 Insulin Pumps Market in Israel, till 2035 (Million Units Sold, USD Billion)
Table 22.117 Insulin Pumps Market in Egypt, till 2035 (Million Units Sold, USD Billion)
Table 22.118 Insulin Pumps Market in Saudi Arabia, till 2035 (Million Units Sold, USD Billion)
Table 22.119 Insulin Pumps Market in Latin America, till 2035 (Million Units Sold, USD Billion)
Table 22.120 Insulin Pumps Market in Brazil, till 2035 (Million Units Sold, USD Billion)
Table 22.121 Insulin Pumps Market in Argentina, till 2035 (Million Units Sold, USD Billion)
Table 22.122 Insulin Pumps Market in Mexico, till 2035 (Million Units Sold, USD Billion)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Beta Bionics
  • CeQur
  • EOFlow
  • Insulet
  • MannKind
  • Medtronic
  • Medtrum Technologies
  • MicroPort
  • Microtech Medical
  • Roche
  • SOOIL Development
  • Tandem Diabetes Care
  • Terumo
  • Ypsomed
  • ViCentra

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

Insulin Pumps Market by Product, Disease Indication, Accessories, Distribution Channel - Global Forecast 2025-2030 - Product Image

Insulin Pumps Market by Product, Disease Indication, Accessories, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Insulin Patch Pumps Global Market Report 2024 - Product Image

Insulin Patch Pumps Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Insulin Patch Pumps Market by Mode, Product, Disease Indication - Global Forecast 2025-2030 - Product Image

Insulin Patch Pumps Market by Mode, Product, Disease Indication - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Insulin Pump Market Report by Types, Diseases, Accessories, End-user Countries and Company Analysis 2024-2032 - Product Image

Insulin Pump Market Report by Types, Diseases, Accessories, End-user Countries and Company Analysis 2024-2032

  • Report
  • 210 Pages
  • Global
From
Insulin Pumps Market Report by Product Type (Insulin Pumps, Insulin Pump Supplies and Accessories), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers, and Others), and Region 2024-2032 - Product Image

Insulin Pumps Market Report by Product Type (Insulin Pumps, Insulin Pump Supplies and Accessories), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers, and Others), and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From

About the Insulin Pump Market

The Insulin Pump market is a subset of the larger Diabetes Devices market. Insulin pumps are medical devices used to deliver insulin to people with diabetes. They are typically worn on the body and are programmed to deliver a continuous, steady dose of insulin throughout the day. Insulin pumps are used to help people with diabetes maintain their blood sugar levels and reduce the risk of complications associated with diabetes. Insulin pumps are typically used by people with type 1 diabetes, as well as some people with type 2 diabetes. They are also used by pregnant women with diabetes, as well as children and adolescents. Insulin pumps are becoming increasingly popular as they offer more flexibility and convenience than traditional insulin injections. Some of the companies in the Insulin Pump market include Medtronic, Insulet, Tandem Diabetes Care, Animas, and Roche. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.